Reduction of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody by Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis

J Clin Rheumatol. 2021 Dec 1;27(8S):S806-S807. doi: 10.1097/RHU.0000000000001453.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*
  • Antibodies, Antineutrophil Cytoplasmic
  • Antibodies, Monoclonal, Humanized
  • Churg-Strauss Syndrome* / diagnosis
  • Churg-Strauss Syndrome* / drug therapy
  • Female
  • Granulomatosis with Polyangiitis*
  • Humans
  • Microscopic Polyangiitis*
  • Peroxidase

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Antibodies, Monoclonal, Humanized
  • mepolizumab
  • Peroxidase